Medicenna Therapeutics Corp (TSX:MDNA)
C$ 2.4 0.03 (1.27%) Market Cap: 183.44 Mil Enterprise Value: 147.81 Mil PE Ratio: 0 PB Ratio: 8.02 GF Score: 42/100

Medicenna Therapeutics Corp Annual Shareholders Meeting Transcript

Sep 21, 2022 / 02:00PM GMT
Release Date Price: C$1.14 (-0.87%)
Operator

Ladies and gentlemen, welcome to the Annual Meeting of Shareholders of Medicenna Therapeutics Corp. Please note the meeting is being recorded. I would like to introduce Dr. Fahar Merchant, Chairman and Board of Director -- of the Board of Directors. Dr. Merchant, please go ahead.

Fahar Merchant
Medicenna Therapeutics Corp. - Founder, Chairman, President & CEO

Thank you. The Annual Meeting of Shareholders of Medicenna Therapeutics Corp. will now come to order. My name is Dr. Fahar Merchant, and I'm Chairman of the Board of Directors of the Corporation. I will preside as Chairman of the meeting, and I hereby appoint Mr. Charles-Antoine Soulière of McCarthy Tetrault LLP to act as Secretary of the meeting.

To mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders resulting from the unprecedented public health impact of COVID-19, we have opted for a virtual-only annual general meeting. In making the decision to hold a virtual meeting, it was paramount to ensure that shareholder rights were protected.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot